Organic Acids (Urine): Normal vs. Functional Optimal Ranges

What Organic Acids in Urine Actually Measure

Organic acids are carbon-containing compounds produced as intermediates or end products of amino acid catabolism, fatty acid beta-oxidation, the citric acid (Krebs) cycle, neurotransmitter turnover, and microbial metabolism in the gut. A urine organic acids test captures a snapshot of these pathways by quantifying the concentration of each metabolite per milligram of creatinine 1.

The test uses GC-MS, the same analytical method that clinical genetics laboratories employ to diagnose inborn errors of metabolism such as methylmalonic acidemia and maple syrup urine disease 2. When the same technology is applied with a broader analyte menu and interpreted against tighter reference intervals, it becomes the organic acids test (OAT) used in functional medicine settings.

Each marker on the panel maps to a specific enzymatic step. Elevated adipic acid, for example, suggests impaired mitochondrial beta-oxidation. High levels of hydroxymethylglutaric acid (HMG) point toward CoA metabolism disruption. Suberic acid elevation may reflect a carnitine-dependent transport bottleneck 3. The clinical question is not whether a single marker sits inside or outside a population-derived range. It is whether the pattern across multiple related markers reveals a metabolic bottleneck worth addressing.

How Conventional Reference Ranges Are Built

Conventional lab reference ranges represent the central 95% of values in an apparently healthy reference population. This is standard practice for clinical chemistry, codified in the Clinical and Laboratory Standards Institute (CLSI) EP28-A3c guideline 4. The method works well for analytes with tight physiological regulation, like serum sodium or calcium. It works less well for metabolites whose concentrations shift substantially based on diet, microbiome composition, and nutrient cofactor status.

For organic acids, the reference population often includes individuals with undiagnosed subclinical nutrient depletions. A 2009 cross-sectional analysis found that 23% of U.S. adults aged 19 to 50 had serum vitamin B6 concentrations below 20 nmol/L, a threshold associated with impaired transamination 5. If a quarter of the "healthy" reference group is B6-insufficient, then markers downstream of B6-dependent enzymes (xanthurenate, kynurenate) will have inflated upper limits. The reference range accommodates the insufficiency rather than flagging it.

That is the core critique from the functional medicine perspective. The range tells you whether a patient looks like the general population. It does not tell you whether the patient's metabolic machinery is running at full capacity.

Functional Optimal Ranges: Where They Come From

Functional ranges derive from a different logic. Instead of asking "what values do most people have?", they ask "at what substrate or cofactor level does enzyme activity plateau?" This approach draws on nutrient-repletion kinetics and metabolic flux studies.

Consider methylmalonic acid (MMA), one of the most clinically validated organic acid markers. The conventional upper limit for urine MMA is approximately 3.8 mcg/mg creatinine in most commercial labs. The functional threshold used by many integrative practitioners sits near 2.0 mcg/mg creatinine. That tighter cutoff comes from studies showing that MMA concentrations above 2.0 are associated with tissue-level B12 insufficiency even when serum B12 remains within the conventional range of 200 to 900 pg/mL 6.

A 2014 systematic review in the American Journal of Clinical Nutrition evaluated 26 studies on MMA as a biomarker of B12 status and concluded that elevated MMA detected functional B12 deficiency in 25% to 50% of patients with "normal" serum B12, particularly among older adults 6. The Endocrine Society does not publish specific organic acid guidelines, but the society's clinical practice recommendations for vitamin D assessment reflect the same principle: the difference between "not deficient" and "sufficient for optimal function" is clinically meaningful 7.

The weakness of functional ranges is that they are less standardized. Different labs and practitioners apply different cutoffs, and few have been validated in prospective outcome trials. The strength is that they catch patterns, particularly in B-vitamin status, mitochondrial energy output, and neurotransmitter metabolism, that conventional ranges miss.

Key Organic Acid Categories and What They Reveal

Fatty Acid Oxidation Markers

Adipate, suberate, and ethylmalonate reflect how efficiently mitochondria burn long-chain fatty acids for fuel. Elevations in this cluster suggest carnitine insufficiency, riboflavin (B2) depletion, or primary mitochondrial dysfunction 3. Conventional ranges flag only extreme elevations consistent with genetic fatty acid oxidation disorders (MCADD, VLCADD). Functional cutoffs sit 30% to 50% lower, targeting the zone where supplemental carnitine or riboflavin demonstrably reduces metabolite concentrations in repletion studies 8.

Krebs Cycle Intermediates

Citrate, succinate, fumarate, malate, and alpha-ketoglutarate trace the flow of acetyl-CoA through mitochondrial energy production. A low citrate-to-succinate ratio may indicate impaired aconitase activity, which is sensitive to iron status and oxidative stress. Elevated succinate has gained attention as an oncometabolite and a marker of pseudohypoxia in succinate dehydrogenase (SDH) dysfunction 9.

In clinical practice, isolated Krebs cycle abnormalities are hard to interpret. Pattern recognition across the full cycle matters more than any single value. The functional approach groups these markers and looks for upstream bottlenecks (CoQ10 depletion, NAD+ insufficiency) rather than treating each analyte independently.

B-Vitamin Functional Markers

This is the strongest clinical application of functional organic acid interpretation. Specific metabolites map to specific cofactors with well-characterized biochemistry:

• Methylmalonate rises with B12 insufficiency (methylmalonyl-CoA mutase requires adenosylcobalamin) 6
• Xanthurenate and kynurenate rise with B6 insufficiency (kynureninase requires pyridoxal-5-phosphate) 10
• Formiminoglutamate (FIGLU) rises with folate insufficiency (formiminotransferase requires tetrahydrofolate) 11
• Alpha-ketoisovalerate, alpha-ketoisocaproate rise with thiamine (B1) or lipoic acid depletion (branched-chain alpha-keto acid dehydrogenase complex)

The tryptophan challenge test, which loads patients with L-tryptophan and measures downstream xanthurenate excretion, has been a validated B6 assessment method for decades 10. Functional organic acid panels essentially perform a version of this assessment under basal dietary conditions.

Neurotransmitter Metabolites

Homovanillic acid (HVA), vanillylmandelic acid (VMA), 5-hydroxyindoleacetic acid (5-HIAA), and quinolinate trace dopamine, norepinephrine, serotonin, and neuroinflammatory tryptophan metabolism respectively. Conventional labs measure these primarily to screen for catecholamine-secreting tumors (pheochromocytoma, neuroblastoma) with correspondingly high upper limits 12.

Functional practitioners use lower cutoffs and ratios (HVA:VMA, quinolinate:kynurenate) to infer neurotransmitter turnover rates. This application has less published validation than the B-vitamin markers. A 2017 review in the Journal of Clinical Medicine noted that while urinary neurotransmitter metabolites correlate with central nervous system turnover, the relationship is confounded by peripheral metabolism, dietary amine intake, and medication effects 13.

Microbial Organic Acids

D-arabinitol, tartarate, hippurate, benzoate, and several phenolic compounds originate from gut microbial metabolism. Elevated D-arabinitol has been proposed as a marker of Candida overgrowth, based on studies showing that Candida species produce this polyol during fermentation 14. The sensitivity and specificity of D-arabinitol for clinically significant candidiasis remain debated; a 2006 meta-analysis reported pooled sensitivity of 81% and specificity of 86% for invasive candidiasis, but the test performs differently in the non-invasive dysbiosis context where OAT panels typically apply it 14.

Hippurate, produced from microbial metabolism of dietary polyphenols and benzoate conjugation with glycine, serves as a crude marker of microbial diversity. The MetaHIT consortium found that urinary hippurate concentrations correlated positively with gut microbial gene richness across 292 subjects 15. Low hippurate on an OAT panel may prompt further investigation with stool metagenomics or a targeted elimination diet.

Clinical Limitations You Should Know

Organic acid testing has real blind spots. Urine concentration varies with hydration status, and while creatinine normalization partially corrects for this, it introduces its own error in patients with low muscle mass or renal impairment. A 2018 study in Clinical Chemistry found that creatinine-adjusted urine analytes showed up to 25% variation between first-morning and random specimens in the same individual 16.

Diet exerts a strong acute effect. Tartarate spikes after grape or wine consumption. Benzoate and hippurate shift with berry and preservative intake. Citrate drops with low fruit and vegetable diets. Patients need to follow a standardized pre-collection protocol (avoiding specific foods for 48 hours) to produce interpretable results.

Perhaps the most significant limitation: no major medical society, including the American Association of Clinical Endocrinology (AACE), the Endocrine Society, or the U.S. Preventive Services Task Force (USPSTF), currently endorses routine organic acid screening in the general population 7. The test is validated for inborn errors of metabolism in pediatric populations. Its expanded use in adult functional medicine rests on biochemical plausibility and small repletion studies, not on randomized trials demonstrating that OAT-guided supplementation improves hard clinical endpoints.

When Organic Acid Testing Makes Clinical Sense

Despite these limitations, specific clinical scenarios justify the test. Patients with unexplained fatigue who have already had normal CBC, CMP, TSH, and iron studies may benefit from the mitochondrial and B-vitamin sections of an OAT panel. A 2012 study in Nutrition and Metabolism found that 38% of patients presenting to a fatigue clinic with normal routine labs had at least one organic acid marker outside the functional optimal range, with B12-related MMA elevation being the most common finding 8.

Patients on metformin deserve special mention. Long-term metformin use reduces B12 absorption by 10% to 30%, and a 2010 randomized trial (N = 390) published in the BMJ showed that metformin users had significantly higher MMA concentrations than placebo, confirming tissue-level B12 depletion 17. For these patients, urine MMA may catch B12 insufficiency that serum B12 alone misses.

Post-bariatric surgery patients, individuals on proton pump inhibitors for over 12 months, and patients with documented malabsorption syndromes also represent reasonable candidates for organic acid assessment, given their elevated risk of multiple concurrent micronutrient depletions 18.

How to Interpret Your Results Practically

Do not interpret organic acid markers in isolation. A single elevated methylmalonate means little without a concurrent serum B12 and holotranscobalamin measurement. A single elevated adipate could reflect a high-fat meal the day before collection rather than a carnitine deficit.

The interpretive approach that produces the most clinically actionable information involves three steps. First, identify clusters of related markers that are all shifted in the same direction (two or more fatty acid oxidation markers elevated together carry more weight than one). Second, correlate the organic acid findings with serum nutrient levels and clinical symptoms. Third, treat the identified insufficiency with targeted repletion and retest in 90 to 120 days to confirm normalization.

As Dr. Richard Lord, a clinical chemist who co-developed the Metametrix organic acids panel, noted in a 2005 review: "The value of organic acid profiling lies not in any single marker but in the constellation of metabolic perturbations that, taken together, point toward a specific biochemical lesion" 1.

The American Association of Clinical Chemistry (AACC) recommends that organic acid testing for inborn errors be performed in CLIA-certified laboratories using validated GC-MS or tandem mass spectrometry methods 2. When ordering functional panels, verify that the performing laboratory holds CAP accreditation and participates in proficiency testing programs such as the College of American Pathologists (CAP) Biochemical Genetics survey.

Retest intervals of three to four months after beginning targeted supplementation allow sufficient time for metabolic pools to equilibrate and provide meaningful before-and-after comparison data.